BONESUPPORT, a leading company in orthobiologics for the management of bone injuries, today announces that the company has received CE certification for its products CERAMENT BONE VOID FILLER and CERAMENT V under the new EU MDR (EU MDR 2017/745). The EU Medical Device Regulation was introduced to further raise the bar regarding quality and safety of medical devices in Europe. BONESUPPORT has previously received MDR certification of CERAMENT® G and the quality management system. Thereby the full product portfolio is MDR certified.

For more information contact:

BONESUPPORT Holding AB
Emil Billbäck, CEO
+46 (0) 46 286 53 70

Håkan Johansson, CFO
+46 (0) 46 286 53 70
ir@bonesupport.com

Cord Communications
Charlotte Stjerngren
+46 (0) 708 76 87 87
charlotte.stjerngren@cordcom.se
www.cordcom.se

About BONESUPPORT™

BONESUPPORT (Nasdaq Stockholm: BONEX) develops and commercializes innovative injectable bio-ceramic bone graft substitutes that remodel to the patient’s own bone and have the capability of eluting drugs. BONESUPPORT’s bone graft substitutes are based on the patented technology platform CERAMENT. The company is conducting several clinical studies to further demonstrate the clinical and health economic benefits its products deliver. The company is based in Lund, Sweden, and the net sales amounted to SEK 329 million in 2022. Please visit www.bonesupport.com for more information.
BONESUPPORT and CERAMENT are registered trademarks of BONESUPPORT AB.

Attachments

BONESUPPORT receives MDR certification for CERAMENT® BONE VOID FILLER and CERAMENT® V

© Modular Finance, source Nordic Press Releases